Sugammadex after magnesium sulphate administration in a morbidly obese patient undergoing general anaesthesia.
Padova, Italy.
M
M
Carron
D000732:Androstanols / Q000008:administration & dosage; D000768:Anesthesia, General / Q000379:methods*; D000777:Anesthetics / Q000008:administration & dosage*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D008278:Magnesium Sulfate / Q000008:administration & dosage*; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology; D009767:Obesity, Morbid / Q000150:complications / Q000601:surgery*; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000008:administration & dosage*
D000732:Androstanols; D000777:Anesthetics; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D008278:Magnesium Sulfate; D000077123:Rocuronium